CLINICAL_TRIALS trial_result · 2023-10-04

Clinical Trial Update: A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus [Phase 1]

Phase 1 trial updating on infusion site pain after infusion of excipients in participants with Type 1 Diabetes Mellitus; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2023-10-04